2010年某院分离细菌的分布及其耐药性分析(2)
综上所述，多重耐药已成为临床治疗感染的一大难题，临床工作中应密切关注医院感染的发生，在诊疗过程中加强合理用药的认识，增加抗感染知识的积累，实行规范化使用抗菌药物，临床经验用药与药敏结果相结合，加强医院的感染管理，强化预防与控制措施，共同努力使医院感染率降低，提高患者治愈率。
参考文献
[1]王爽，宋志香,等.耐甲氧西林金黄色葡萄球菌感染的临床特征、耐药性及治疗研究进展. 实用医院临床杂志，2009， 6(4):137-139.
[2]Srinivasan A, Dick JD, Perl TM. Vancomycin resistance in Staphylococci. Clin Microbiol Rev, 2002, 15(3) : 430-438.
[3]National Committee for Clinical Laboratory Standards. Perfermance standards for antimierobial susceptibility testing. Eleventh informational supplement. M100-S11.Pennsylvania: NCCLS, 2001.
[4]Yuan M, Aucken H, Hall LM, et al. D. M. Epidemioiogical typing of klebsiellae with extended-spectrumbeta-lactamases from European intensive care units. J Antimicrob. Chemother,1998，41(5)：527-539.
[5]Lecaillon E,Gueudet P,Wooton M,et al.Endemic heteroresistant glycopeptide intermediate Staphylcoccus aureus (hGISA) comprising unrelated clonal types and not associated with vancomycin therapy.Pathol Biol (Paris),2002，50(9):525-529.
[6]林建平，潘品福,等 铜绿假单胞菌感染的临床分布及耐药性分析. 检验医学，2007，22(6)：724-726.
[7]Afzal-Shah M, Livermore DM. Worldwide emergence of carbapenemresistant. Acinetobacter spp. J Antimicrob Chemother, 1998, 41:576-577.
[8]Corbela X, M ontero A, Pujol M, et al. Emergence and rapid spread of carbapenem resistance during a large and sustained hospital outbreak of multiresistant Acinetobacterb aumannii.J Clin Microbial, 2000, 38: 4086-4095., http://www.100md.com(吴松武 陈珮瑶 范喜城 王亚力 蔡德 汤丹灵 苏洁玲)
参考文献
[1]王爽，宋志香,等.耐甲氧西林金黄色葡萄球菌感染的临床特征、耐药性及治疗研究进展. 实用医院临床杂志，2009， 6(4):137-139.
[2]Srinivasan A, Dick JD, Perl TM. Vancomycin resistance in Staphylococci. Clin Microbiol Rev, 2002, 15(3) : 430-438.
[3]National Committee for Clinical Laboratory Standards. Perfermance standards for antimierobial susceptibility testing. Eleventh informational supplement. M100-S11.Pennsylvania: NCCLS, 2001.
[4]Yuan M, Aucken H, Hall LM, et al. D. M. Epidemioiogical typing of klebsiellae with extended-spectrumbeta-lactamases from European intensive care units. J Antimicrob. Chemother,1998，41(5)：527-539.
[5]Lecaillon E,Gueudet P,Wooton M,et al.Endemic heteroresistant glycopeptide intermediate Staphylcoccus aureus (hGISA) comprising unrelated clonal types and not associated with vancomycin therapy.Pathol Biol (Paris),2002，50(9):525-529.
[6]林建平，潘品福,等 铜绿假单胞菌感染的临床分布及耐药性分析. 检验医学，2007，22(6)：724-726.
[7]Afzal-Shah M, Livermore DM. Worldwide emergence of carbapenemresistant. Acinetobacter spp. J Antimicrob Chemother, 1998, 41:576-577.
[8]Corbela X, M ontero A, Pujol M, et al. Emergence and rapid spread of carbapenem resistance during a large and sustained hospital outbreak of multiresistant Acinetobacterb aumannii.J Clin Microbial, 2000, 38: 4086-4095., http://www.100md.com(吴松武 陈珮瑶 范喜城 王亚力 蔡德 汤丹灵 苏洁玲)